Javitt DC - Search Results

1

Neurophysiological biomarkers for drug development in schizophrenia.

Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M. Javitt DC, et al. Nat Rev Drug Discov. 2008 Jan;7(1):68-83. doi: 10.1038/nrd2463. Nat Rev Drug Discov. 2008. PMID: 18064038 Free PMC article. Review.

2

Associated deficits in mismatch negativity generation and tone matching in schizophrenia.

Javitt DC, Shelley A, Ritter W. Javitt DC, et al. Clin Neurophysiol. 2000 Oct;111(10):1733-7. doi: 10.1016/s1388-2457(00)00377-1. Clin Neurophysiol. 2000. PMID: 11018486 Free article.

3

Management of negative symptoms of schizophrenia.

Javitt DC. Javitt DC. Curr Psychiatry Rep. 2001 Oct;3(5):413-7. doi: 10.1007/s11920-996-0036-9. Curr Psychiatry Rep. 2001. PMID: 11559479 Review.

4

Adjunctive high-dose glycine in the treatment of schizophrenia.

Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR. Javitt DC, et al. Int J Neuropsychopharmacol. 2001 Dec;4(4):385-91. doi: 10.1017/S1461145701002590. Int J Neuropsychopharmacol. 2001. PMID: 11806864 Free article. Clinical Trial.

5

Glycine modulators in schizophrenia.

Javitt DC. Javitt DC. Curr Opin Investig Drugs. 2002 Jul;3(7):1067-72. Curr Opin Investig Drugs. 2002. PMID: 12186269 Review.

6

Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology.

Butler PD, DeSanti LA, Maddox J, Harkavy-Friedman JM, Amador XF, Goetz RR, Javitt DC, Gorman JM. Butler PD, et al. Among authors: javitt dc. Schizophr Res. 2003 Feb 1;59(2-3):199-209. doi: 10.1016/s0920-9964(01)00341-3. Schizophr Res. 2003. PMID: 12414076

7

Decoding schizophrenia.

Javitt DC, Coyle JT. Javitt DC, et al. Sci Am. 2004 Jan;290(1):48-55. doi: 10.1038/scientificamerican0104-48. Sci Am. 2004. PMID: 14682038 No abstract available.

8

Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia.

Schechter I, Butler PD, Zemon VM, Revheim N, Saperstein AM, Jalbrzikowski M, Pasternak R, Silipo G, Javitt DC. Schechter I, et al. Among authors: javitt dc. Clin Neurophysiol. 2005 Sep;116(9):2204-15. doi: 10.1016/j.clinph.2005.06.013. Clin Neurophysiol. 2005. PMID: 16055375 Free PMC article. Clinical Trial.

9

Magnocellular contributions to impaired motion processing in schizophrenia.

Kim D, Wylie G, Pasternak R, Butler PD, Javitt DC. Kim D, et al. Among authors: javitt dc. Schizophr Res. 2006 Feb 15;82(1):1-8. doi: 10.1016/j.schres.2005.10.008. Epub 2005 Dec 1. Schizophr Res. 2006. PMID: 16325377 Free PMC article.

10

Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients.

Javitt DC. Javitt DC. Curr Opin Psychiatry. 2006 Mar;19(2):151-7. doi: 10.1097/01.yco.0000214340.14131.bd. Curr Opin Psychiatry. 2006. PMID: 16612195 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters